Fenoldopam

Generic Name: Fenoldopam

Brand Names: Corlopam

Drug Type: Small Molecule

Chemical Formula: C_₁₆H_₁₆ClNO_₃

CAS Number: 67227-56-9

Unique Ingredient Identifier: INU8H2KAWG

Overview

A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Indication

用于极严重高血压或住院不能口服药物的高血压患者初1～2天的对症处理。

Associated Conditions

Malignant Hypertension
Severe Hypertension

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants	2015/12/03	NCT02620761	Phase 2	Terminated	Medical College of Wisconsin
Fenoldopam for Prevention of Acute Kidney Injury	2012/09/24	NCT01690832	Phase 4	UNKNOWN	University of Roma La Sapienza
Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet	2011/03/28	NCT01324245	Not Applicable	Completed	Georgetown University
Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury	2010/02/23	NCT01073189	Phase 4	Withdrawn	Southeast Renal Research Institute
Fenoldopam in Pediatric Cardiac Surgery	2009/09/23	NCT00982527	Phase 3	Completed	Bambino Gesù Hospital and Research Institute
Fenoldopam and Splanchnic Perfusion During Cardiopulmonary Bypass	2008/09/05	NCT00747331	Phase 4	Completed	IRCCS Policlinico S. Donato
The Effect of Fenoldopam in Solitary Partial Nephrectomy Surgery	2008/08/28	NCT00743106	Not Applicable	Terminated	The Cleveland Clinic
Fenoldopam and Acute Renal Failure	2008/02/22	NCT00621790	Phase 3	Completed	Università Vita-Salute San Raffaele
Effect of Gene Variants on Dopamine Receptor Natriuretic Responses	2008/01/11	NCT00592150	Phase 1	UNKNOWN	University of Virginia
Fenoldopam and Ketanserin for Acute Kidney Failure Prevention After Cardiac Surgery	2007/11/12	NCT00557219	Phase 3	Terminated	Medical University of Gdansk

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Corlopam	Hospira, Inc.	0409-3373	INTRAVENOUS	10 mg in 1 mL	8/10/2021

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

Related News

No news found

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.